Here are the 424B prospectus supplements from Neo-Concept International Group Holdings Limited (NCI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow NCI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NCI filings page.
Neo-Concept International Group Holdings Ltd. (NCI) is offering 250,000 Class A Ordinary Shares at US$1.00 each and 1,750,000 Pre-Funded Warrants at US$0.99 each; the offering also covers 1,750,000 Class A Ordinary Shares issuable upon exercise at US$0.01 per share. The aggregate offering price is US$2,000,000, assuming full warrant exercise.
NCI estimates net proceeds of approximately US$1.81 million after placement agent fees and estimated offering expenses, for working capital and other general corporate purposes. The warrants are immediately exercisable and remain exercisable until fully exercised, subject to a 4.99% beneficial-ownership limit, or 9.99% if elected. Delivery is expected on or about October 1, 2026, subject to customary closing conditions.
Assuming full exercise, NCI states it will cease to be a controlled company immediately after the offering; chairman and CEO Pengfei Jiang would beneficially own approximately 3.06% of ordinary shares and represent approximately 48.60% of voting power.
Neo-Concept International Group Holdings Limited is offering up to 14,850,000 Class A Ordinary Shares at a fixed price of US$0.5454 per share in a best-efforts primary offering. If fully placed, gross proceeds would be about US$8.10 million, with approximately US$7.69 million to the company before expenses after a 5.0% placement commission.
The shares are already listed on Nasdaq under “NCI,” and this deal is not subject to any minimum amount or escrow, so any funds raised will be immediately available for use. Investors buy equity in a Cayman holding company whose operations run through subsidiaries in Hong Kong, the UK and the UAE, and may never directly own interests in those operating entities.
The prospectus highlights significant risks, including potential PRC regulatory overreach affecting Hong Kong, evolving cybersecurity and CSRC/CAC filing regimes, and U.S. rules under the HFCAA and AHFCAA that could ultimately lead to trading prohibitions if auditors cannot be fully inspected. The company has not paid dividends and expects to retain earnings, while a controlling shareholder will continue to hold majority voting power through a dual-class structure after the offering.